Stay updated on Depemokimab in Severe Asthma Clinical Trial

Sign up to get notified when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Depemokimab in Severe Asthma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a new publication entry for Safety and Tolerability of Twice-Yearly Depemokimab in Patients with Asthma and Chronic Rhinosinusitis with Nasal Polyps: Pooled Results from SWIFT-1/-2 and ANCHOR-1/-2 (Adv Ther, 2026; doi: 10.1007/s12325-025-03457-4) and removed the 2025 ahead-of-print reference. The study record version has been updated to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T09:28:25.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added in place of v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T16:59:19.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and Revision: v3.4.0 was removed.
    Difference
    0.0%
    Check dated 2026-02-06T11:01:18.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now shows a glossary and the last QC-update label has been changed to 'Last Update Submitted that Met QC Criteria'. Revision metadata has been updated to 'Revision: v3.4.0' (replacing the previous v3.3.4) and 'No FEAR Act Data' capitalization adjusted.
    Difference
    0.1%
    Check dated 2026-01-29T03:12:02.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown, replacing the previous v3.3.3 on the page.
    Difference
    0.0%
    Check dated 2026-01-14T01:44:01.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Added a publication entry related to the study, including a PubMed note for a related article (Safety and Tolerability of Twice-Yearly Depemokimab...). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-06T20:47:39.000Z thumbnail image

Stay in the know with updates to Depemokimab in Severe Asthma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.